Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Aadi Bioscience, Inc. ?
1
Poor Management Efficiency with a low ROE of 2.73%
- The company has been able to generate a Return on Equity (avg) of 2.73% signifying low profitability per unit of shareholders funds
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 75.12%, its profits have risen by 73.6%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Aadi Bioscience, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Aadi Bioscience, Inc.
75.12%
1.53
69.41%
S&P 500
14.9%
0.77
19.29%
Quality key factors
Factor
Value
Sales Growth (5y)
-0.84%
EBIT Growth (5y)
-286.74%
EBIT to Interest (avg)
-48.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.04
Sales to Capital Employed (avg)
0.23
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
83.76%
ROCE (avg)
0
ROE (avg)
2.73%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.17
EV to EBIT
-0.20
EV to EBITDA
-0.20
EV to Capital Employed
-3.95
EV to Sales
1.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-9.94%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
Technical Movement
5What is working for the Company
NET PROFIT(9M)
Higher at USD 2.66 MM
CASH AND EQV(HY)
Highest at USD 339.8 MM
-18What is not working for the Company
NET SALES(9M)
At USD 7.14 MM has Grown at -61.88%
PRE-TAX PROFIT(Q)
At USD -17.75 MM has Fallen at -79.11%
NET PROFIT(Q)
At USD -17.75 MM has Fallen at -79.11%
OPERATING CASH FLOW(Y)
Lowest at USD -95.25 MM
RAW MATERIAL COST(Y)
Grown by 101.14% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.57 times
Here's what is working for Aadi Bioscience, Inc.
Cash and Eqv
Highest at USD 339.8 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Aadi Bioscience, Inc.
Net Sales
At USD 7.14 MM has Grown at -61.88%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -17.75 MM has Fallen at -79.11%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -17.75 MM has Fallen at -79.11%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -95.25 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Lowest at 0.57 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 101.14% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






